Bills › 90th General Assembly
SF 2159Withdrawn · HF 2668 became law instead · April 9, 2024
Relating to insurance coverage for biomarker testing
Sponsored by the Senate Commerce Committee
Topics:Business & economyMedicaid
Where it is now
- Done: IntroducedJanuary 9, 2024
- Done: SubcommitteeJanuary 9, 2024
- Done: Senate committeeJanuary 30, 2024
- Done: Passes the SenateApril 9, 202446–0
- Skipped: House committeeSkipped
- Done: Passes the HouseMarch 27, 202496–1
- Done: To the GovernorApril 23, 2024
- Done: Signed into lawMay 1, 2024
HF 2668 became law → The same legislation passed as HF 2668, so this version was set aside. Go to HF 2668 What’s a funnel?
What changed before it passed The bill as introduced compared with the version both chambers passed.
Amendments · 5
2 adopted · 0 failed · 3 never voted on. Newest first.
- H-8294 · filed April 9, 2024 byNever voted onPage 1, by striking lines 14 through 17 and inserting: “c. “Clinical utility” means sufficient medical and scientific evidence indicating that the use of a biomarker test will provide meaningful information that affects…
- S-5124 · filed April 8, 2024 by Sen. Waylon Brown (R)AdoptedPage 1, by striking lines 14 through 17 and inserting: “c. “Clinical utility” means sufficient medical and scientific evidence indicating that the use of a biomarker test will provide meaningful information that affects…April 9, 2024
- S-5123Strike everything · filed April 8, 2024 by Sen. Waylon Brown (R)AdoptedReplaces the whole bill with new text.Amends this SF 2159 to CONFORM to HF 2668April 9, 2024
- H-8050 · filed February 26, 2024 byNever voted onPage 1, after line 7 by inserting: “___. Page 2, by striking lines 16 and 17 and inserting “testing has demonstrated clinical utility, or when the biomarker testing is considered to be a medically necessary service for…
- H-8022 · filed February 19, 2024 byNever voted onPage 1, by striking lines 14 through 17 and inserting: “c. “Clinical utility” means the test result provides information that is used in the formulation of a treatment or monitoring strategy that informs a patient’s… (2 changes)